| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.04▲ | 2.04▲ | 2.03▲ | 2.06▼ | 1.93▲ |
| MA10 | 2.03▲ | 2.03▲ | 2.01▲ | 2.04▲ | 1.89▲ |
| MA20 | 2.04▲ | 2.01▲ | 2.02▲ | 1.93▲ | 2.01▲ |
| MA50 | 2.02▲ | 2.04▲ | 2.05▼ | 1.88▲ | 1.95▲ |
| MA100 | 2.01▲ | 2.04▲ | 1.95▲ | 2.02▲ | 3.80▼ |
| MA200 | 2.03▲ | 1.93▲ | 1.88▲ | 1.97▲ | 5.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.007▲ | 0.004▲ | 0.013▲ | 0.013▲ |
| RSI | 64.040▲ | 58.190▲ | 54.811▲ | 57.244▲ | 51.127▲ |
| STOCH | 50.000 | 89.487▲ | 82.875▲ | 61.183 | 38.524 |
| WILL %R | 0.000▲ | 0.000▲ | -15.385▲ | -38.824 | -66.346 |
| CCI | 175.000▲ | 87.410 | 144.200▲ | 22.138 | 32.993 |
|
Monday, December 01, 2025 11:09 PM
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat ...
|
|
Tuesday, September 02, 2025 01:02 AM
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today ...
|
|
Friday, April 08, 2022 06:24 AM
SOUTH SAN FRANCISCO, Calif., April 08, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/01/26 | 1.96 | 2.05 | 1.94 | 2.05 | 934,431 |
| 15/01/26 | 2.07 | 2.07 | 1.96 | 1.96 | 956,148 |
| 14/01/26 | 2.05 | 2.10 | 2.04 | 2.07 | 546,551 |
| 13/01/26 | 2.17 | 2.18 | 2.05 | 2.05 | 790,648 |
| 12/01/26 | 2.10 | 2.19 | 2.04 | 2.18 | 794,330 |
| 09/01/26 | 2.12 | 2.14 | 2.035 | 2.09 | 722,431 |
| 08/01/26 | 2.03 | 2.215 | 2.00 | 2.11 | 1,582,935 |
| 07/01/26 | 1.94 | 2.08 | 1.94 | 2.06 | 1,401,034 |
| 06/01/26 | 1.89 | 1.96 | 1.89 | 1.93 | 586,832 |
| 05/01/26 | 1.87 | 1.91 | 1.84 | 1.90 | 417,114 |
|
|
||||
|
|
||||
|
|